A Common Variant in the Adaptor Mal Regulates Interferon Gamma Signaling
Immunity 44(2): 368-379
Article 2016 English
Authors
CC
Clíona Ní Cheallaigh
FS
Frederick J. Sheedy
JH
James Harris
Abstract
1 min read
Humans that are heterozygous for the common S180L polymorphism in the Toll-like receptor (TLR) adaptor Mal (encoded by TIRAP) are protected from a number of infectious diseases, including tuberculosis (TB), whereas those homozygous for the allele are at increased risk. The reason for this difference in susceptibility is not clear. We report that Mal has a TLR-independent role in interferon-gamma (IFN-γ) receptor signaling. Mal-dependent IFN-γ receptor (IFNGR) signaling led to mitogen-activated protein kinase (MAPK) p38 phosphorylation and autophagy. IFN-γ signaling via Mal was required for phagosome maturation and killing of intracellular Mycobacterium tuberculosis (Mtb). The S180L polymorphism, and its murine equivalent S200L, reduced the affinity of Mal for the IFNGR, thereby compromising IFNGR signaling in macrophages and impairing responses to TB. Our findings highlight a role for Mal outside the TLR system and imply that genetic variation in TIRAP may be linked to other IFN-γ-related diseases including autoimmunity and cancer.
Christoph Hölscher, Norbert Reiling, Ulrich E. Schaible, Alexandra Hölscher, Clara Bathmann, Daniel S. Korbel, Insa Lenz, Tanja Sonntag, Svenja Kröger, Akira Shizuo, Horst Mossmann, Carsten J. Kirschning, Hermann Wagner, Marina A. Freudenberg, Stefan Ehlers
Mark Hughes, Peter Lavrencic, Rebecca C. Coll, Thomas Ve, Dylan G. Ryan, Niamh C. Williams, Deepthi Menon, Ashley Mansell, Philip G. Board, Mehdi Mobli, Boštjan Kobe, Luke O'neill
Discussion(0)
No comments yet. Be the first to comment.